Why is Evogene Ltd. ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
- Poor long term growth as Net Sales has grown by an annual rate of 40.32% and Operating profit at 6.99% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
2
Flat results in Sep 25
- NET SALES(HY) At USD 1.2 MM has Grown at -55.87%
- INVENTORY TURNOVER RATIO(HY) Lowest at 2.47 times
- RAW MATERIAL COST(Y) Grown by 252.69% (YoY)
3
Risky -
- The stock is trading risky as compared to its average historical valuations
- Over the past year, while the stock has generated a return of -36.53%, its profits have risen by 63.6%
4
Below par performance in long term as well as near term
- Along with generating -36.53% returns in the last 1 year, the stock has also underperformed S&P 500 in the last 3 years, 1 year and 3 months
How much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Evogene Ltd. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Evogene Ltd.
-39.01%
-0.68
127.02%
S&P 500
13.68%
0.71
19.28%
Quality key factors
Factor
Value
Sales Growth (5y)
40.32%
EBIT Growth (5y)
6.99%
EBIT to Interest (avg)
-15.16
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.52
Sales to Capital Employed (avg)
-0.76
Tax Ratio
0.05%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
10.33%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
6.04
EV to EBIT
0.57
EV to EBITDA
0.65
EV to Capital Employed
0.59
EV to Sales
-1.60
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
103.74%
ROE (Latest)
-810.16%
11What is working for the Company
OPERATING CASH FLOW(Y)
Highest at USD -16.56 MM
NET PROFIT(HY)
Higher at USD -7.36 MM
ROCE(HY)
Highest at 0%
OPERATING PROFIT(Q)
Highest at USD -2.43 MM
DEBT-EQUITY RATIO
(HY)
Lowest at -1,176.71 %
EPS(Q)
Highest at USD 0.44
-13What is not working for the Company
NET SALES(HY)
At USD 1.2 MM has Grown at -55.87%
INVENTORY TURNOVER RATIO(HY)
Lowest at 2.47 times
RAW MATERIAL COST(Y)
Grown by 252.69% (YoY
CASH AND EQV(HY)
Lowest at USD 27.65 MM
NET PROFIT(Q)
At USD -4.05 MM has Fallen at -23.73%
Here's what is working for Evogene Ltd.
Operating Profit
Highest at USD -2.43 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Operating Cash Flow
Highest at USD -16.56 MM
in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
EPS
Highest at USD 0.44
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debt-Equity Ratio
Lowest at -1,176.71 %
in the last five Semi-Annual periodsMOJO Watch
The company has been reducing its borrowing as compared to equity capital
Debt-Equity Ratio
Here's what is not working for Evogene Ltd.
Net Sales
At USD 1.2 MM has Grown at -55.87%
Year on Year (YoY)MOJO Watch
Near term sales trend is very negative
Net Sales (USD MM)
Inventory Turnover Ratio
Lowest at 2.47 times and Fallen
In each half year in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
Net Profit
At USD -4.05 MM has Fallen at -23.73%
over average net sales of the previous four periods of USD -3.28 MMMOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 27.65 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 252.69% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales






